Top 10 Electric Utility Stocks To Own For 2014

By Hal M. Bundrick

NEW YORK (MainStreet) -- Wall Street is pass� The real money is in that new app startup you just found out about -- or in a biotech breakthrough you really believe in. And with new crowdfunding investments set to explode, big upside deals will seem to be everywhere. Real estate, oil and gas, new media companies. These non-public investments are the kinds of opportunities more investors are seeking these days, particularly the young and wealthy, as they look beyond traditional public stock market offerings and choose to open the investment door marked "Private."

A recent survey conducted by iCrowd revealed that nearly half (49%) of high net worth investors under the age of 30 are currently invested in private placements. One-in-five wealthy investors between 45-60 years of age are, too.

Top 5 Low Price Companies To Watch In Right Now: Great Lakes Dredge & Dock Corporation(GLDD)

Great Lakes Dredge & Dock Corporation engages in the business of marine construction, primarily dredging, and commercial and industrial demolition primarily in the east, west, and Gulf Coasts of the United States. The company?s Dredging segment is involved in capital dredging projects consisting of primarily port expansion projects, land reclamations, trench digging for pipelines, tunnels and cables, and other dredging related to the construction of breakwaters, jetties, and canals; beach nourishment projects, which involve moving sand from the ocean floor to shoreline locations; and maintenance dredging that includes the re-dredging of previously deepened waterways and harbors to remove silt, sand, and other accumulated sediments, as well as lake and river dredging, inland levee and construction dredging, environmental restoration, and habitat improvement. Its Demolition segment provides commercial and industrial demolition services. It is involved in exterior demolition that comprises dismantling and demolition of structures and foundations; and interior demolition, which includes removing specific structures within a building. This segment also engages in site development, removal of asbestos and other hazardous materials, and remediation of contaminated demolition materials. The company serves federal, state, and local governments; foreign governments; domestic and foreign private concerns, such as utilities and oil companies; general contractors; corporations that commission projects; nonprofit institutions, such as universities and hospitals; and local government and municipal agencies. It has a fleet of 33 dredges, including 8 deployed internationally; 19 material transportation barges; 2 drill boats; and various other specialized support vessels. The company was formerly known as Lydon & Drews Partnership and changed its name to Great Lakes Dredge & Dock Corporation in 1905. The company was founded in 1809 and is headquartered in Oak Brook, Illinois.

Advisors' Opinion:

• [By Seth Jayson]

  There's no foolproof way to know the future for Great Lakes Dredge & Dock (Nasdaq: GLDD  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

Top 10 Electric Utility Stocks To Own For 2014: MagneGas Corp (MNGA)

MagneGas Corporation, incorporated on December 09, 2005, is an alternative energy company that creates and produces hydrogen based alternative fuel through the gasification of liquid waste. The Company has developed a process which transforms various types of liquid waste through a plasma arc machine. The result of the product is to carbonize the waste for normal disposal. A byproduct of this process is to produce an alternative to natural gas sold in the metalworking market. The Company produces gas bottled in cylinders for the purpose of distribution to the metalworking markets as an alternative to acetylene. In addition, the Company markets, for sale or licensure, its plasma arc technology. Through the course of the Company's business development, the Company has established a retail and wholesale platforms to sell its fuel for use in the metalworking and manufacturing industries. In August 2012, the Company purchased a 3.5 acre site in Tarpon Springs, FL.

The Company focuses on producing and selling fuels and equipment for the metalworking fuel market. The Company has distributors in Pennsylvania, Alabama, Michigan and Florida. The Company also has a retail operation in Florida selling fuel directly to end users. The Company has obtained approval from the Department of Transportation to deliver fuel in Florida and has several customers purchasing fuel directly. The Company has two products: the fuel called MagneGas and the machines that produce that gas known as Plasma Arc Flow refineries. The Company produces MagneGas for the metalworking market from a feedstock of virgin ethylene glycol (automotive anti-freeze) which is purchased in bulk from outside suppliers. The fuel is hydrogen based and can be used to replace natural gas. It is sold as a replacement for acetylene in the metalworking market. The Plasma Arc Flow technology can gasify many forms of liquid waste such as ethylene glycol, sewage and sludge. Plasma Arc Flow refineries are configured in various sizes ranging from 50kil! owatts (KW) to 500KW depending on the application.

Advisors' Opinion:

• [By James E. Brumley]

  Truth be told, had MagneGas Corporation (NASDAQ:MNGA) shares not surged 400% - and subsequently tumbled - in early January, it might not even be worth looking at now. MNGA did surge then, however, so what we've seen unfurl over the past few days can't be ignored now... as it suggests this small hydrogen supplier stock is about to take flight in a more controlled and longer-lasting way than it did at the beginning of the year.

• [By James E. Brumley]

  You're welcome. Back on March 12th when yours truly penned some bullish thoughts on MagneGas Corporation (NASDAQ:MNGA), nobody cared, largely because nobody had heard of the company, and there was no particular reason anybody had to find MNGA. Now less than a full week later, this once-obscure name is all the rage; no less than 21 different market-centric websites have made mention of the stock's explosive growth over the past few days. MagneGas has been proverbially put on the map, with shares surging 90% (as of right now) since the first exploration last Wednesday. So, like I said, you're welcome.... if you got in on the 12th, or even more realistically, got in on the 14th when MNGA finally crossed above the ceiling at $0.94 I was talking about a little less than a week ago.

Top 10 Electric Utility Stocks To Own For 2014: Ophthotech Corp (OPHT)

Ophthotech Corporation, incorporated on January 05, 2007, is a biopharmaceutical company specializing in the development of therapeutics to treat diseases of the eye. The Company�� advanced product candidate is Fovista, which the Company is developing for use in combination with anti-VEGF drugs that represent the current standard of care for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is a serious disease of the central portion of the retina, known as the macula, which is responsible for detailed central vision and color perception. It is characterized by abnormal new blood vessel formation and growth, referred to as neovascularization, which results in blood vessel leakage, retinal distortion and scar formation. If untreated, the progressive retinal damage results in rapid, irreversible and severe vision loss. Wet AMD is the cause of blindness in patients over the age of 55 in the United States and the European Union.

The anti-VEGF market for the treatment of wet AMD consists predominantly of two drugs that are approved for marketing and primarily prescribed for the treatment of wet AMD, Lucentis and Eylea, and off-label use of the cancer therapy Avastin. The use of anti-VEGF drugs has significantly improved visual outcomes for patients with wet AMD who have been treated with these drugs as compared to untreated patients.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Shares of Ophthotech (NASDAQ: OPHT) got a boost, shooting up 25.78 percent to $39.54 after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.

• [By John Udovich]

  Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%�plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.

Top 10 Electric Utility Stocks To Own For 2014: TrustCo Bank Corp NY(TRST)

TrustCo Bank Corp NY operates as the holding company for Trustco Bank that provides general banking services to individuals, partnerships, and corporations. The company primarily involves in accepting deposits, and making loans and investments. It also serves as the executor of estates and trustee of personal trusts; provides asset and wealth management, estate planning and related advice, and custodial services; and acts as the trustee for various types of employee benefit plans, and corporate pension and profit sharing trusts. In addition, the company operates a real estate investment trust that acquires, holds, and manages real estate mortgage assets, including residential mortgage loans and mortgage-backed securities. As of December, 2010, it operated 141 automatic teller machines and 134 banking offices in Albany, Columbia, Dutchess, Greene, Orange, Rensselaer, Rockland, Saratoga, Schenectady, Schoharie, Ulster, Warren, Washington, and Westchester counties in New York ; Charlotte, Hillsborough, Lake, Manatee, Orange, Osceola, Polk, Sarasota, Seminole, and Volusia counties in Florida; Bennington County in Vermont; Berkshire County in Massachusetts; and Bergen County in New Jersey. The company was founded in 1902 and is headquartered in Glenville, New York.

Advisors' Opinion:

• [By Rick Munarriz]

  Monday
  The market kicks off with TrustCo (NASDAQ: TRST  ) reporting quarterly results on Monday. Many of the "too big to fail" institutions reported in recent days, but now it's time to check out some of the regional players. TrustCo has 138 offices through the Northeast and Florida, watching over $4.3 billion in assets.

Top 10 Electric Utility Stocks To Own For 2014: Amyris Inc.(AMRS)

Amyris, Inc., an integrated renewable products company, provides alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The company uses its industrial synthetic biology platform to modify microorganisms, primarily yeast, to convert plant-sourced sugars into a variety of hydrocarbon molecules that serve as flexible building blocks to be used in a range of products. It is also involved in the sale of ethanol and ethanol blended gasoline to wholesale customers through a network of terminals primarily in the southeastern Unites States. In addition, the company sells farnesene or Biofene, which is used as an ingredient in a range of consumer and industrial products, including detergents, cosmetics, perfumes, and industrial lubricants. Further, it focuses on the commercialization of renewable diesel and jet fuel. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc . in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Advisors' Opinion:

• [By Maxx Chatsko]

  He believes several companies have set the bar precipitously low to start the year despite targeted developments expected to occur before the start of 2014. Watch the following video for his thoughts on potential positive surprises awaiting investors in�Amyris� (NASDAQ: AMRS  ) ,�BioAmber� (NYSE: BIOA  ) ,�Codexis� (NASDAQ: CDXS  ) , and�Solazyme� (NASDAQ: SZYM  ) .

• [By Robert Rapier]

  KiOR (Nasdaq: KIOR) is one of three advanced biofuel companies that venture capitalist Vinod Khosla took public in 2011. The other two were Amyris (Nasdaq: AMRS) and Gevo (Nasdaq: GEVO). Each of these companies has seen its share price drop sharply since the IPO. While KiOR is one of the few companies to have produced advanced biofuel for sale, the volumes have consistently come in below company guidance, and I expect production costs to remain above the sales price for the foreseeable future.

• [By Maxx Chatsko]

  I imagine the company has made headway since its initial press release, especially with commissioning for its Moema, Brazil, biorefinery looming. When updates are given on commercial achievements in the months ahead, will you be able to digest the important information that affects your investments? Heading into the homestretch of the first wave of commercial buildout, it is crucially important to understand what Solazyme, Gevo (NASDAQ: GEVO  ) , and�Amyris� (NASDAQ: AMRS  ) spill in press releases -- and the greater detail given in SEC filings.

Top 10 Electric Utility Stocks To Own For 2014: Astellas Pharma Inc (ALPMY.PK)

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, chronic hepatitis C, irritable bowel syndrome, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, agrypnia, atopic dermatitis and other diseases. Advisors' Opinion:

• [By Henry Kawabe]

  Seattle Genetic is currently collaborating on 22 different ADC drug trials in various stages of testing with twelve different pharmaceutical companies, including nine with Genentech (RHHBY.OB), two with AbbVie (ABBV), two with Agensys (ALPMY.PK), and one with Pfizer (PFE). To date, these ADC collaborations have generated more than $225 million for Seattle Genetics and have the potential to generate more than $3.5 billion in milestone payments plus royalties.

Top 10 Electric Utility Stocks To Own For 2014: Guggenheim CurrencyShares Australian Dollar Trust (FXA)

Guggenheim CurrencyShares Australian Dollar Trust, formerly The CurrencyShares Australian Dollar Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Australian Dollars and distributes Australian Dollars in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Australian Dollars plus accrued interest, if any, less the expenses of the Trust�� operations. The Shares are intended to offer investors an opportunity to participate in the market for the Australian Dollar through an investment in securities. The Shares are bought and sold on New York Stock Exchange (NYSE) Arca like any other exchange-listed security.

The Trust holds Australian Dollars and, from time to time, issues Baskets in exchange for deposits of Australian Dollars and distributes Australian Dollars in connection with redemptions of Baskets. The Sponsor of the Trust oversees the performance of the Trustee and the Trust�� principal service providers. The Sponsor is Rydex Specialized Products LLC. The Sponsor is responsible for payment of administrative and marketing expenses. The Bank of New York Mellon serves as the Trustee. The Trustee is responsible for the day-to-day administration of the Trust, including keeping the Trust�� operational records. JPMorgan Chase Bank, N.A., London Branch is the Depository.

Advisors' Opinion:

• [By Richard Cox]

  Finally, the Australian Dollar has moved to new lows for the year, and prices in the AUD/USD will be forced to contend with another 61.8% Fib retracement (of the move from 0.8060 seen in 2010). This suggests the declines are in need of a corrective bound and equates to a bearish bias in the CurrencyShares Australian Dollar Trust (FXA).

• [By Fede Zaldua]

  The easiest way to go short Australia's currency and long the US dollar is through selling Australian dollar's ETF, the Currency Shares Australian Dollar Trust (FXA), which is still held by John Keeley. Even when the ETF is down by 15% since 2013 started, I believe there is still significant downside potential for the currency.

• [By Dr. Duru]

  The closest real justification for the rate cut comes via the stubbornly high exchange rate of the Australian dollar (FXA) and low credit demand:

  The exchange rate, on the other hand, has been little changed at a historically high level over the past 18 months, which is unusual given the decline in export prices and interest rates during that time. Moreover, the demand for credit remains, at this point, relatively subdued.

• [By Dr. Duru]

  So, the slight change of wording in the first sentence of the statement is important in that it could be a precursor to other upside adjustments in the RBA's language. If this happens, the Australian dollar (FXA) could take off…exactly what the RBA does not want. In fact, its desire to contain the currency must underlie the strained attempts to contain enthusiasm over the economy.